Insurers have waived cost sharing for COVID-19 but that would not apply to Medicare beneficiaries who haven't purchased Medigap policies.
Insurers and the federal government had taken steps to insulate Americans from cost sharing related to COVID-19 testing and treatment, but the Kaiser Family Foundation (KFF) noted today that a group of 6 million seniors and young people with disabilities without supplemental Medicare coverage (Medigap) could still be hit with large hospital bills.
Moreover, a large proportion (39%) of these Americans without supplemental coverage have per capita incomes of less than $20,000 or less, according to a foundation analysis of 2017 CMS data.
The foundation's expert calculate that COVID-19 patients covered by Medicare who don’t have a supplemental policy will face, at a minimum, a $1,408 payment for inpatient care before they meet their deductible. If they need nursing home care, they will face additional bills.
Older people are disproportionately affected by COVID-19 infections that require hospitalization, so presumably some COVID-19 patients are in this financially vulnerable position.
Most, if not all, private insurers, including Medicare Advantage plans, have moved to waive cost sharing for COVID-19 care. Americans who are uninsured have also been insulated from COVID-19-related bills. The Trump administration said earlier this month that it will use some of the $100 billion earmarked for hospitals to cover the cost of COVID-19 patients without insurance.
The Kaiser experts noted that COVID-19 patients in high-deductible plans may also be facing a large expense if their insurer did not waive cost sharing.
This week on Tuning Into The C-Suite Briana Contreras spoke with Dr. Scott Hayworth, president and CEO of New York-based CareMount Medical. In this interview, the two discussed the importance of patients staying in contact with their doctors for the sake of reducing public health risks and to discuss ongoing care options with them.
Listen
Eric Levin talks PBMs and how Scripta is Tackling the Market's Challenges for Patients
July 22nd 2020MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.
Listen